跳至主要内容
临床试验/ACTRN12624000166572
ACTRN12624000166572尚未招募Unknown

A pilot study to investigate the feasibility of a combined exercise and nutrition prehabilitation program for patients with endometrial cancer scheduled for surgery

King Edward Memorial Hospital0 个研究点目标入组 20 人开始时间: 2024年2月22日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • 1.Low grade (grade 1) endometrioid endometrial adenocarcinoma
  • 2.Presumed early stage (Federation of Gynecology and Obstetrics stage 1A) on physical
  • examination and imaging (CT chest, abdomen, and pelvis)
  • 3.At least one of the following cardiovascular risk factors: overweight (BMI greater than or
  • equal to 25kg/m2) or obese (BMI greater than or equal to 30kg/m2), hypertension, type
  • 2 diabetes, hypercholesterolaemia, self-reported physical inactivity (less than 150
  • minutes per week of moderate activity such as walking, gardening, swimming, cycling,
  • gym), smoking
  • 4.Planned to undergo definitive surgery (total hysterectomy, bilateral salpingo-
  • oophorectomy +/- sentinel lymph node biopsies)
  • 5.Age 18 years or older
  • 6.Able to understand study requirements, attend regular appointments with the exercise
  • physiologist and dietitian, and complete the home exercise logbook
  • 7.European Cooperative Oncology Group (ECOG) performance status less than or equal

排除标准

  • 1.Medical contraindication to exercise or the use of a very low-calorie diet, including
  • physical impairments, lactation, presence of porphyria, severe hepatic disease,
  • advanced renal disease, unstable cardiac disease (recent myocardial infarction or
  • unstable angina), type 1 diabetes mellitus, overt psychosis, alcoholism, or drug abuse
  • 2.Patients on lithium, corticosteroids, anticonvulsants (although not a contraindication to
  • Optifast, requires extra monitoring beyond the scope of this study)
  • 3.Evidence of extra-uterine disease clinically or on medical imaging
  • 4.Histological cell types including serous, clear cell, carcinosarcoma, sarcoma, de-
  • differentiated
  • 5.Moderately differentiated or poorly differentiated (grades 2 and 3) endometrioid
  • adenocarcinoma
  • 6.Grade 1 endometrioid adenocarcinoma where the treatment plan is for fertility
  • preservation/conservative management
  • 7.Inability to give informed consent
  • 8.European Cooperative Oncology Group (ECOG) performance status greater than or

研究者

相似试验